Key Facts
• The term ‘anti-involution’ gained attention after Xi Jinping’s July 2025 meeting.
• Policy aims to curb excessive price competition and overproduction in key industries.
• Targeted sectors include solar energy, EVs, and steel, suffering from declining profitability.
• UBS sees the policy as a strong signal against destructive competition.
• CSI 300 Index rose 2% in July, outperforming Hong Kong’s H-Share Index.
• Analysts expect supply-side reforms to improve pricing and profit margins.
• Overproduction now spans consumer sectors like healthcare and food, unlike 2015-2018.
• Morgan Stanley prioritizes mainland stocks over Hong Kong-listed Chinese shares.
• Experts compare the policy to past supply-side reforms but note key differences.
• Challenges include addressing private-sector overproduction and boosting domestic consumption.
Summary
China’s ‘anti-involution’ policy, introduced during a July 2025 meeting led by Xi Jinping, aims to address excessive price competition and overproduction in industries like solar energy, EVs, and steel. This policy shift has sparked optimism among investors, with the CSI 300 Index rising 2% in July, outperforming Hong Kong’s H-Share Index. Analysts anticipate supply-side reforms to improve pricing and profitability, though challenges remain, including overproduction in private-sector industries and weak domestic consumption. Experts liken the policy to 2015-2018 reforms but highlight broader sectoral impacts and complexities. UBS and Morgan Stanley view the policy as a positive signal, prioritizing mainland stocks over offshore counterparts.
